Bibo Tan

2.0k total citations
103 papers, 1.4k citations indexed

About

Bibo Tan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Bibo Tan has authored 103 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 32 papers in Pulmonary and Respiratory Medicine and 32 papers in Cancer Research. Recurrent topics in Bibo Tan's work include Gastric Cancer Management and Outcomes (23 papers), MicroRNA in disease regulation (17 papers) and RNA modifications and cancer (17 papers). Bibo Tan is often cited by papers focused on Gastric Cancer Management and Outcomes (23 papers), MicroRNA in disease regulation (17 papers) and RNA modifications and cancer (17 papers). Bibo Tan collaborates with scholars based in China, United States and Norway. Bibo Tan's co-authors include Liqiao Fan, Qun Zhao, Yong Li, Yong Li, Peigang Yang, Dong Wang, Yuan Tian, Zhidong Zhang, Xuefeng Zhao and Lei Bao and has published in prestigious journals such as PLoS ONE, Medicine and Cell Death and Disease.

In The Last Decade

Bibo Tan

101 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bibo Tan China 22 790 558 290 255 190 103 1.4k
Hua Xiao China 22 508 0.6× 276 0.5× 309 1.1× 356 1.4× 364 1.9× 91 1.3k
Ying Lv China 24 633 0.8× 329 0.6× 384 1.3× 304 1.2× 346 1.8× 102 1.5k
Yoshitaka Sekine Japan 20 502 0.6× 401 0.7× 429 1.5× 244 1.0× 256 1.3× 89 1.3k
Jing Kong China 22 807 1.0× 449 0.8× 206 0.7× 412 1.6× 226 1.2× 67 1.6k
Yuping Yin China 26 798 1.0× 290 0.5× 324 1.1× 337 1.3× 194 1.0× 63 1.6k
Zheng Zhu China 20 834 1.1× 577 1.0× 378 1.3× 440 1.7× 278 1.5× 41 1.6k
Julita Machlowska Poland 8 434 0.5× 304 0.5× 462 1.6× 273 1.1× 381 2.0× 14 1.1k
Hesheng Luo China 28 1.0k 1.3× 561 1.0× 182 0.6× 398 1.6× 232 1.2× 62 1.8k
Ignacio Romero Spain 23 476 0.6× 218 0.4× 302 1.0× 420 1.6× 279 1.5× 98 1.5k

Countries citing papers authored by Bibo Tan

Since Specialization
Citations

This map shows the geographic impact of Bibo Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bibo Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bibo Tan more than expected).

Fields of papers citing papers by Bibo Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bibo Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bibo Tan. The network helps show where Bibo Tan may publish in the future.

Co-authorship network of co-authors of Bibo Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Bibo Tan. A scholar is included among the top collaborators of Bibo Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bibo Tan. Bibo Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yingying, et al.. (2025). LINC02679 regulates TRIML2 to promote gastric cancer proliferation and invasion via targeting miR-5004-3p. Non-coding RNA Research. 13. 1–14. 1 indexed citations
2.
Liu, Qingwei, Yong Li, Bibo Tan, et al.. (2024). LncRNA HAGLR regulates gastric cancer progression by regulating the miR-20a-5p/E2F1 axis. Aging. 16(16). 11843–11856. 2 indexed citations
3.
Wang, Bingyu, et al.. (2024). Targeting LINC00665/miR-199b-5p/SERPINE1 axis to inhibit trastuzumab resistance and tumorigenesis of gastric cancer via PI3K/AKt pathway. Non-coding RNA Research. 10. 153–162. 6 indexed citations
4.
Wang, Bingyu, Wenbo Liu, Mingming Zhang, et al.. (2024). Circ_0001947 encapsulated by small extracellular vesicles promotes gastric cancer progression and anti-PD-1 resistance by modulating CD8+ T cell exhaustion. Journal of Nanobiotechnology. 22(1). 563–563. 11 indexed citations
5.
Wang, Bingyu, et al.. (2024). Mapping spatial heterogeneity in gastric cancer microenvironment. Biomedicine & Pharmacotherapy. 172. 116317–116317. 4 indexed citations
6.
Wang, Bingyu, et al.. (2023). The Regulatory Mechanism and Research Progress of Ferroptosis in Gastric Cancer. Technology in Cancer Research & Treatment. 22. 2223910386–2223910386. 8 indexed citations
7.
Ding, Ping’an, Bibo Tan, Hongyan Wang, et al.. (2023). Screening of Differentially Expressed Genes Based on the ACRG Molecular Subtypes of Gastric Cancer and the Significance and Mechanism of AGTR1 Gene Expression. Journal of Personalized Medicine. 13(3). 560–560. 6 indexed citations
8.
Wang, Bingyu, et al.. (2023). Advances in the Mechanism of Action of Neutrophil Extracellular Traps in Gastrointestinal Tumors: A Review. International Journal of General Medicine. Volume 16. 2783–2789. 1 indexed citations
9.
Fan, Liqiao, Qun Zhao, Yu Liu, et al.. (2022). Family history of malignant tumor is a predictor of gastric cancer prognosis: Incorporation into a nomogram. Medicine. 101(35). e30141–e30141. 3 indexed citations
10.
Li, Yong, Bibo Tan, Qun Zhao, et al.. (2021). Up-regulation of KLF17 expression increases the sensitivity of gastric cancer to 5-fluorouracil. International Journal of Immunopathology and Pharmacology. 35. 3938481517–3938481517. 6 indexed citations
11.
Tian, Yuan, Qun Zhao, Yong Li, et al.. (2021). Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma. Gastroenterology Research and Practice. 2021. 1–7. 6 indexed citations
12.
Li, Fang, Bibo Tan, Qiang Ji, et al.. (2020). Relationship between HER2 expression and tumor interstitial angiogenesis in primary gastric cancer and its effect on prognosis. Pathology - Research and Practice. 217. 153280–153280. 12 indexed citations
13.
Li, Fang, Bibo Tan, Yueping Liu, et al.. (2019). Influential factors and prognostic analysis of blood vessel invasion in advanced gastric cancer. Pathology - Research and Practice. 216(3). 152727–152727. 13 indexed citations
14.
Zhao, Qun, Yong Li, Peigang Yang, et al.. (2018). Evaluation for therapeutic measures to small gastric stromal tumor: A retrospective study of 90 cases. Current Problems in Cancer. 42(1). 107–114. 3 indexed citations
15.
Ji, Qiang, et al.. (2018). KLF11 promotes gastric cancer invasion and migration by increasing Twist1 expression. Neoplasma. 66(1). 92–100. 20 indexed citations
16.
Wang, Jun, Jun Zhang, Xueying Qiao, et al.. (2015). Concurrent Neoadjuvant Chemoradiotherapy for Siewert II and III Adenocarcinoma at Gastroesophageal Junction. The American Journal of the Medical Sciences. 349(6). 472–476. 19 indexed citations
17.
Tan, Bibo, et al.. (2015). HIF-1α Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a. PLoS ONE. 10(8). e0132746–e0132746. 54 indexed citations
18.
Li, Yong, Bibo Tan, Qun Zhao, et al.. (2014). Regulatory mechanism of ZNF139 in multi-drug resistance of gastric cancer cells. Molecular Biology Reports. 41(6). 3603–3610. 15 indexed citations
19.
Tan, Bibo, et al.. (2014). Inhibition of Vav3 could reverse the drug resistance of gastric cancer cells by downregulating JNK signaling pathway. Cancer Gene Therapy. 21(12). 526–531. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026